India Pharma 2026

India Pharma 2026 India Pharma 2026

India Pharma 2023 - An International Conference on Pharmaceutical Industry is a joint initiative of the Department of Pharmaceuticals, Government of India, and Federation of Indian Chambers of Commerce & Industry (FICCI) to provide a common platform where all the participants will get an opportunity to enhance their brand value by displaying their product and the capabilities among the conference

delegates and business visitors provided by the event. India Pharma 2023 covers the whole process of Pharmaceutical Manufacturing, from various kinds of manufacturing/processing machinery to Lab Equipment, Analytical Instruments, APIs, and other total solutions.

02/05/2026

Mr. Kunal Bansal, Chief Digital Officer, Mankind Pharma, emphasised at India Pharma 2026 that collaborative platforms and technological advancements will play a central role in shaping the next phase of growth for India’s pharmaceutical industry.

30/04/2026

Mr. Peter Bains, Managing Director and Chief Executive Officer, Syngene International Limited, noted at India Pharma 2026 that open dialogue and shared insights among industry participants can help accelerate India’s progress in the global biopharmaceutical ecosystem.

29/04/2026

Dr. Seema Pai, President, Indian Society for Clinical Research, and Head, Pfizer India, emphasised at India Pharma 2026 that the convergence of funding, startups, regulatory pathways, and emerging technologies such as AI is enabling a more holistic approach to drug development and patient access.

28/04/2026

Bhushan Akshikar, Managing Director, GSK, and President, Organisation of Pharmaceutical Producers of India, highlighted at India Pharma 2026 that building a strong innovation ecosystem will be critical to advancing early-stage research and ensuring faster access to new therapies for patients in India.

27/04/2026

Winselow Tucker, Co-Chair, FICCI Pharma Committee and President and General Manager, Eli Lilly & Company (India), highlighted at India Pharma 2026 that collaborative platforms enable alignment on shared priorities and accelerate progress towards India’s long-term pharmaceutical innovation goals.

25/04/2026

Dr. Renu Swarup, Former Secretary to Government of India, Department of Biotechnology, Ministry of Science & Technology, New Delhi, India, emphasised at India Pharma 2026 that continuous engagement and collective participation are critical to ensuring that reforms remain dynamic and responsive to the evolving needs of the pharmaceutical sector.

24/04/2026

Mr. Shreehas Tambe, Chief Executive Officer and Managing Director, Biocon Limited, stated at India Pharma 2026 that the pharmaceutical sector in India is witnessing a decisive shift from volume-driven growth to value-led leadership, with a stronger focus on capabilities and innovation.

23/04/2026

“From being the pharmacy of the world to becoming a global innovation leader, that’s the journey ahead.”

At India Pharma 2026, Meenal Gauri, Managing Director, Boehringer Ingelheim, shared her perspective on the power of collaboration, bringing together industry, government, and global stakeholders to put innovation at the centre of patient care.

22/04/2026

“Innovation is here to stay and India is ready to lead the next phase.”

At India Pharma 2026, Mr. Amitabh Dube, Country President & Managing Director, Novartis highlighted the importance of a robust innovation ecosystem, predictable regulatory frameworks, and the need to scale capabilities to position India as a global innovation powerhouse.

21/04/2026

Smt. Punya Salila Srivastava, Secretary, Ministry of Health & Family Welfare, Government of India, highlighted at India Pharma 2026 that collaborative inputs from industry will be critical in shaping a unified digital regulatory platform that supports transparency and strengthens governance.

21/04/2026

Dr. Rajiv Bahl, Secretary, Department of Health Research, Ministry of Health & Family Welfare, and Director-General, Indian Council of Medical Research (ICMR), stated at India Pharma 2026 that sustained government commitment to research and development is being reinforced through continuous engagement with industry stakeholders.

Address

Delhi

Telephone

+919711581760

Website

Alerts

Be the first to know and let us send you an email when India Pharma 2026 posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to India Pharma 2026:

Shortcuts

Share